The challenge of curtailing the escalation of counterfeit pharmaceuticals

Peggy E. Chaudhry

Chapter 8 in Handbook of Research on Counterfeiting and Illicit Trade, 2017, pp 157-192 from Edward Elgar Publishing

Abstract: In this chapter, the discussion centers around the size and growth of illegitimate pharmaceuticals; the porous supply chain in both physical and virtual markets, which allows illicit traders to penetrate (or circumvent) the licit trade of pharmaceuticals; a succinct clarification of both formal organized crime groups and informal illicit traders fueling the supply; the evolution of agencies designed to govern and enforce this type of criminal activity; and an array of anti-counterfeiting tactics designed to curb this major problem.

Keywords: Business and Management; Economics and Finance; Law - Academic (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/view/9781785366444.00017.xml (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Temporarily Unavailable

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:17096_8

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().